Healthcare provider profile · identity verified

Aida E Castro, M.D.

Internal Medicine · TAMPA, FL · NPI 1164450698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	941	272
Amlodipine Besylate	Amlodipine Besylate	866	228
Atorvastatin Calcium	Atorvastatin Calcium	708	204
Levothyroxine Sodium	Levothyroxine Sodium	659	157
Losartan Potassium	Losartan Potassium	556	156
Metformin Hcl	Metformin Hcl	443	115
Pantoprazole Sodium	Pantoprazole Sodium	409	100
Fluticasone Propionate	Fluticasone Propionate	373	144
Gabapentin	Gabapentin	373	95
Lisinopril	Lisinopril	354	109
Alprazolam	Alprazolam	322	67
Sertraline Hcl	Sertraline Hcl	320	93
Famotidine	Famotidine	288	74
Omeprazole	Omeprazole	255	65
Albuterol Sulfate Hfa	Albuterol Sulfate	254	81
Metoprolol Succinate	Metoprolol Succinate	233	72
Hydrochlorothiazide	Hydrochlorothiazide	218	59
Clopidogrel	Clopidogrel Bisulfate	211	52
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	177	43
Metoprolol Tartrate	Metoprolol Tartrate	177	41
Montelukast Sodium	Montelukast Sodium	158	41
Mometasone Furoate	Mometasone Furoate	150	33
Simvastatin	Simvastatin	146	44
Ketoconazole	Ketoconazole	142	30
Carvedilol	Carvedilol	135	39
Nystatin	Nystatin	132	43
Diclofenac Sodium	Diclofenac Sodium	130	27
Escitalopram Oxalate	Escitalopram Oxalate	128	35
Trazodone Hcl	Trazodone Hcl	121	31
Esomeprazole Magnesium	Esomeprazole Magnesium	120	18
Eliquis	Apixaban	115	31
Meloxicam	Meloxicam	115	38
Ezetimibe	Ezetimibe	112	41
Ibandronate Sodium	Ibandronate Sodium	110	28
Donepezil Hcl	Donepezil Hcl	107	25
Triamcinolone Acetonide	Triamcinolone Acetonide	105	48
Jardiance	Empagliflozin	102	22
Ozempic	Semaglutide	102	21
Baclofen	Baclofen	97	47
Olmesartan Medoxomil	Olmesartan Medoxomil	95	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	92	30
Dicyclomine Hcl	Dicyclomine Hcl	91	14
Felodipine Er	Felodipine	91	21
Furosemide	Furosemide	88	26
Allopurinol	Allopurinol	87	22
Mupirocin	Mupirocin	87	55
Temazepam	Temazepam	87	12
Clonazepam	Clonazepam	84	15
Meclizine Hcl	Meclizine Hcl	82	33
Atenolol	Atenolol	81	24
Duloxetine Hcl	Duloxetine Hcl	81	21
Mounjaro	Tirzepatide	78	15
Clonidine Hcl	Clonidine Hcl	77	22
Glimepiride	Glimepiride	77	20
Januvia	Sitagliptin Phosphate	77	20
Mirtazapine	Mirtazapine	76	22
Alendronate Sodium	Alendronate Sodium	75	24
Hydrocortisone	Hydrocortisone	71	14
Glipizide Er	Glipizide	68	19
Potassium Chloride	Potassium Chloride	67	24
Hydralazine Hcl	Hydralazine Hcl	66	20
Lorazepam	Lorazepam	64	15
Cephalexin	Cephalexin	63	57
Memantine Hcl	Memantine Hcl	63	17
Pioglitazone Hcl	Pioglitazone Hcl	63	24
Doxycycline Hyclate	Doxycycline Hyclate	61	55
Nifedipine Er	Nifedipine	61	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	13
Celecoxib	Celecoxib	58	14
Repatha Sureclick	Evolocumab	57	14
Symbicort	Budesonide/Formoterol Fumarate	55	13
Tamsulosin Hcl	Tamsulosin Hcl	54	19
Ciclopirox	Ciclopirox	53	11
Zolpidem Tartrate	Zolpidem Tartrate	52	suppressed
Azelastine Hcl	Azelastine Hcl	51	17
Prednisone	Prednisone	50	45
Fluoxetine Hcl	Fluoxetine Hcl	49	14
Hydroxyzine Hcl	Hydroxyzine Hcl	49	14
Spironolactone	Spironolactone	49	suppressed
Cefdinir	Cefdinir	47	46
Irbesartan	Irbesartan	47	12
Benazepril Hcl	Benazepril Hcl	46	12
Lidocaine	Lidocaine	46	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	45	13
Trulicity	Dulaglutide	43	suppressed
Torsemide	Torsemide	40	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	39	suppressed
Valsartan	Valsartan	39	11
Dexlansoprazole Dr	Dexlansoprazole	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	35
Lovastatin	Lovastatin	35	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	30
Farxiga	Dapagliflozin Propanediol	34	suppressed
Ibuprofen	Ibuprofen	33	13
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	11
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Ventolin Hfa	Albuterol Sulfate	31	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	30	suppressed
Glipizide	Glipizide	30	suppressed
Nitroglycerin	Nitroglycerin	30	suppressed
Valacyclovir	Valacyclovir Hcl	30	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	30	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	29	suppressed
Sucralfate	Sucralfate	29	suppressed
Lansoprazole	Lansoprazole	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Metformin Hcl Er	Metformin Hcl	27	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	26	suppressed
Chlorthalidone	Chlorthalidone	26	11
Fenofibrate	Fenofibrate	26	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Methylprednisolone	Methylprednisolone	25	22
Candesartan Cilexetil	Candesartan Cilexetil	24	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Prolia	Denosumab	24	14
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Vascepa	Icosapent Ethyl	24	suppressed
Finasteride	Finasteride	23	suppressed
Levemir Flexpen	Insulin Detemir	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	23	suppressed
Azithromycin	Azithromycin	22	21
Labetalol Hcl	Labetalol Hcl	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Ammonium Lactate	Ammonium Lactate	21	suppressed
Naproxen	Naproxen	21	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	21	21
Creon	Lipase/Protease/Amylase	20	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Nebivolol Hcl	Nebivolol Hcl	19	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Veltassa	Patiromer Calcium Sorbitex	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Ramipril	Ramipril	17	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Ofloxacin	Ofloxacin	16	15
Synthroid	Levothyroxine Sodium	16	suppressed
Linzess	Linaclotide	15	suppressed
Metronidazole	Metronidazole	14	suppressed
Rybelsus	Semaglutide	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Sulindac	Sulindac	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Chlordiazepoxide-Amitriptyline	Amitriptyline/Chlordiazepoxide	12	suppressed
Fluconazole	Fluconazole	12	11
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Insulin Aspart Flexpen	Insulin Aspart	12	suppressed
Primidone	Primidone	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error